In the following year, our dedication to quality and compliance bore fruit as we received approval from a multinational company to supply Key Starting Material (KSM). This validation underscored our commitment to adhering to stringent regulatory standards and ensuring the safety and efficacy of our products.
In 2022, another milestone was achieved with the granting of Schedule-M certification, a testament to our adherence to the stringent requirements outlined by regulatory authorities. With this certification in hand, we embarked on the production of Active Pharmaceutical Ingredients (APIs), further expanding our capabilities and reinforcing our position in the pharmaceutical industry.
Our relentless pursuit of excellence culminated in the receipt of the State Good Manufacturing Practices (GMP) certificate. This certification served as a validation of our unwavering commitment to maintaining the highest standards of quality, safety, and efficacy in every aspect of our operations.
In 2023, our efforts were recognized on an international scale as our facility was registered with the USFDA as an API intermediate supplier for clients within the United States. This milestone not only bolstered our reputation as a trusted partner in the pharmaceutical supply chain but also positioned us as a preferred supplier for companies seeking high-quality API intermediates.
